Results 141 to 150 of about 93,278 (240)

Human Respiratory Syncytial Virus and Human Metapneumovirus

, 2009
The human respiratory syncytial virus (hRSV) and the human metapneumovírus (hMPV) are main etiological agents of acute respiratory infections (ARI). The ARI is an important cause of childhood morbidity and mortality worldwide.  hRSV and hMPV are members of the Paramyxoviridae.
da Silva, Luciana Helena Antoniassi, Spilki, Fernando Rosado, Riccetto, Adriana Gut Lopes, Baracat, Emilio Elias, Arns, Clarice Weis   +4 more
openaire   +1 more source

Clinical Interventions During Inter‐hospital Transfer of Infants With Moderate‐to‐Severe Bronchiolitis: Implications for Advanced Nursing Practice

Nursing in Critical Care, Volume 31, Issue 3, May 2026.
ABSTRACT Background Bronchiolitis is a leading cause of hospitalisation and paediatric intensive care admissions in infants. Moderate‐to‐severe cases often require inter‐hospital transfer for respiratory support, usually organised by specialised paediatric emergency transport services (PETS).
Arthur Gaudaire, Christophe Milesi, Alexia Morel, Julien Baleine, Maliha Badr, Alexandra Deveze, Sylvain Paulhac, Marion Palpacuer, Gilles Cambonie, Arthur Gavotto   +9 more
wiley   +1 more source

Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level

Emerging Infectious Diseases, 2022
Ian G. Barr, Thomas C. Williams, Vahid Salimi, Ursula J. Buchholz   +3 more
doaj   +1 more source

Multiplexed detection of eight respiratory viruses based on nanozyme colorimetric microfluidic immunoassay

Frontiers in Bioengineering and Biotechnology
Pandemics caused by respiratory viruses, such as the SARS-CoV-1/2, influenza virus, and respiratory syncytial virus, have resulted in serious consequences to humans and a large number of deaths.
Feng Wu, Feng Wu, Defeng Cai, Defeng Cai, Xueying Shi, Ping Li, Lan Ma, Lan Ma, Lan Ma   +8 more
doaj   +1 more source

A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein. [PDF]

Antimicrob Agents Chemother, 2020
DeVincenzo J, Tait D, Efthimiou J, Mori J, Kim YI, Thomas E, Wilson L, Harland R, Mathews N, Cockerill S, Powell K, Littler E.   +11 more
europepmc   +1 more source

Risk of admission requirement among children with respiratory infection in the post-COVID-19 pandemic era

Journal of Infection and Public Health
Background: To evaluate the effect of the type and codetection of respiratory viruses on admission requirements among children with respiratory infections in the post-COVID-19 pandemic era.
Takahiro Mori, Taito Kitano, Daisuke Kitagawa, Masayuki Murata, Mai Onishi, Soshi Hachisuka, Tenshin Okubo, Naohiro Yamamoto, Hiroki Nishikawa, Masayuki Onaka, Rika Suzuki, Madoka Sekine, Soma Suzuki, Fumihiko Nakamura, Sayaka Yoshida   +14 more
doaj   +1 more source

Respiratory Syncytial Virus among People Living with HIV: Is There a Case for Rolling Out Prophylaxis? A Viewpoint Based on a Systematic Review

Pathogens
Respiratory Syncytial Virus (RSV) is responsible for a considerable burden of respiratory disease among children and older adults. Several prophylactic strategies have recently been introduced.
André Almeida, Raffaele Aliberti, Arianna Aceti, Matteo Boattini   +3 more
doaj   +1 more source

IgG3 snitcher of RSV infections in the very young [PDF]

, 2017
Saelens, Xavier, Schepens, Bert
core   +3 more sources

HBsAg-vectored DNA vaccines elicit concomitant protective responses to multiple CTL epitopes relevant in human disease. [PDF]

, 2008
Vaccines capable of controlling neoplastic and infectious diseases which depend on the cellular immune response for their resolution, have proven difficult to develop.
Allan Gould, Dekun Chen, Jacqueline Kattenbelt, Melanie Barnes, Michael Mather, Oscar Haigh, Robert R. Tindle, Scott Thomson   +7 more
core   +1 more source

Human Respiratory Syncytial Virus [PDF]

, 2020
openaire   +1 more source